Cargando…
Inhibitory effect of metformin combined with gemcitabine on pancreatic cancer cells in vitro and in vivo
Pancreatic cancer is a malignant digestive system tumor with a particularly poor prognosis, and is the fourth leading cause of cancer-associated mortality in the USA. The anti-diabetic therapeutic agent, metformin (MET) has been demonstrated to exert anti-tumor effects. The present study assessed th...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042754/ https://www.ncbi.nlm.nih.gov/pubmed/27499118 http://dx.doi.org/10.3892/mmr.2016.5592 |